Compensation Awarded to Petitioner in Vaccine Injury Claim

Strategic Insights -

In a recent decision, the United States Court of Federal Claims has awarded compensation to Mosel Pearlman-Ramirez in a vaccine injury claim related to the tetanus diphtheria acellular pertussis (Tdap) vaccine. The court's decision follows a stipulation filed by the parties, which acknowledged that the vaccine caused Pearlman-Ramirez to develop Guillain-Barre Syndrome (GBS) and agreed on a compensation amount. The court has approved the requested sum of $110,000.00, which represents all damages available under the National Childhood Vaccine Injury Act of 1986.

Key Takeaways:

  • Mosel Pearlman-Ramirez filed a petition for compensation on June 9, 2022, alleging that the Tdap vaccine caused him to develop GBS.
  • The parties filed a stipulation on May 5, 2023, agreeing to a joint compensation award.
  • The stipulation was adopted as the decision of the court, with the parties agreeing that Pearlman-Ramirez would receive a lump sum of $110,000.00.
  • The court approved the requested compensation amount, which represents all damages available under the National Childhood Vaccine Injury Act of 1986.
  • The decision is publicly accessible on the United States Court of Federal Claims' website.
  • Pearlman-Ramirez has 14 days to identify and move to redact medical or other information that would constitute an unwarranted invasion of privacy.

Statistics:

  • Date of petition filing: June 9, 2022
  • Date of stipulation filing: May 5, 2023
  • Compensation amount: $110,000.00
  • Damages available under the National Childhood Vaccine Injury Act of 1986: All damages

Sources:

  • Decision of the United States Court of Federal Claims, OFFICE OF SPECIAL MASTERS, No. 22-640V (May 8, 2023)
  • National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755